كتاب
Esophageal and Esophagogastric Junction Cancer
- Research gaps
§ Systematic inclusion of cost-benefit analyses in clinical trial with collection of health economic analysis such as incremental cost effectiveness ratio in order to facilitate clinical decision-making.
§ Predictive biomarkers: response to specific systemic targeted therapies and immunotherapy.
§ Improve models for pre-clinical testing of novel drugs.
§ Search for tools to assess quality of life and in clinical trials.
§ Dietary supplements, nutritional counselling, physical activity recommendations and psychological support as part of an integrative healthcare approach to care for people with esophageal cancer.
